Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts

I discussed my "Strong Buy" thesis on Edwards Lifesciences Corporation (NYSE: EW ) in July 2024 and bought the dip after the company cut its guidance in Q2 FY24 . Since then, the stock price has surged by Analyst's Disclosure: I/we have a beneficial long position in the shares of EW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationshi ...